JP2004537596A5 - - Google Patents

Download PDF

Info

Publication number
JP2004537596A5
JP2004537596A5 JP2003519026A JP2003519026A JP2004537596A5 JP 2004537596 A5 JP2004537596 A5 JP 2004537596A5 JP 2003519026 A JP2003519026 A JP 2003519026A JP 2003519026 A JP2003519026 A JP 2003519026A JP 2004537596 A5 JP2004537596 A5 JP 2004537596A5
Authority
JP
Japan
Prior art keywords
compound
arginine
group
oligoguanidine
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003519026A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004537596A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/024645 external-priority patent/WO2003014076A2/en
Publication of JP2004537596A publication Critical patent/JP2004537596A/ja
Publication of JP2004537596A5 publication Critical patent/JP2004537596A5/ja
Pending legal-status Critical Current

Links

JP2003519026A 2001-08-03 2002-08-02 オリゴグアニジン輸送因子の二方向合成 Pending JP2004537596A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31030501P 2001-08-03 2001-08-03
PCT/US2002/024645 WO2003014076A2 (en) 2001-08-03 2002-08-02 Bi-directional synthesis of oligoguanidine transport agents

Publications (2)

Publication Number Publication Date
JP2004537596A JP2004537596A (ja) 2004-12-16
JP2004537596A5 true JP2004537596A5 (cg-RX-API-DMAC10.html) 2006-01-05

Family

ID=23201904

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003519026A Pending JP2004537596A (ja) 2001-08-03 2002-08-02 オリゴグアニジン輸送因子の二方向合成

Country Status (6)

Country Link
US (1) US7067698B2 (cg-RX-API-DMAC10.html)
EP (1) EP1419172A4 (cg-RX-API-DMAC10.html)
JP (1) JP2004537596A (cg-RX-API-DMAC10.html)
CA (1) CA2455951A1 (cg-RX-API-DMAC10.html)
MX (1) MXPA04001142A (cg-RX-API-DMAC10.html)
WO (1) WO2003014076A2 (cg-RX-API-DMAC10.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007038169A2 (en) * 2005-09-23 2007-04-05 Nitto Denko Corporation Multi-valent guanidinium compounds for molecular translocation across cellular membranes and epithelial tissues
WO2007038172A2 (en) * 2005-09-23 2007-04-05 Nitto Denko Corporation Guanidinium carriers
US7700565B2 (en) * 2005-09-23 2010-04-20 Nitto Denko Corporation Peptide nucleic acid based guanidinium compounds
US20100062465A1 (en) * 2006-04-21 2010-03-11 Ronen Sabrina M Detection of Histone Deacetylase Inhibition
US8624006B2 (en) 2007-04-09 2014-01-07 The Regents Of The University Of California One-pot synthesis of alpha/beta-O-glycolipids
PT3149025T (pt) 2014-05-21 2019-08-01 Entrada Therapeutics Inc Peptídeos penetrantes de células e métodos de fabrico e utilização dos mesmos
US10815276B2 (en) 2014-05-21 2020-10-27 Entrada Therapeutics, Inc. Cell penetrating peptides and methods of making and using thereof
WO2016033368A1 (en) 2014-08-27 2016-03-03 Ohio State Innovation Foundation Improved peptidyl calcineurin inhibitors
US11339192B2 (en) 2017-10-04 2022-05-24 Ohio State Innovation Foundation Bicyclic peptidyl inhibitors
EP3746105A4 (en) 2018-01-29 2022-05-18 Ohio State Innovation Foundation CYCLIC PEPTIDYLIN HIBITORS OF THE CAL-PDZ-BINDING DOMAIN
US11576946B2 (en) 2018-01-29 2023-02-14 Ohio State Innovation Foundation Peptidyl inhibitors of calcineurin-NFAT interaction
WO2019165183A1 (en) 2018-02-22 2019-08-29 Entrada Therapeutics, Inc. Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy
WO2019217682A1 (en) 2018-05-09 2019-11-14 Ohio State Innovation Foundation Cyclic cell-penetrating peptides with one or more hydrophobic residues
AU2021386370A1 (en) 2020-11-24 2023-06-22 Lyell Immunopharma, Inc. Methods for making, compositions comprising, and methods of using rejuvenated t cells

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4694086A (en) * 1983-10-05 1987-09-15 Toray Industries, Inc. Guanidine derivatives
EP0684958B1 (en) * 1993-02-17 1998-06-10 Btg International Limited Polymers containing guanidino groups for use in therapy
US5627194A (en) * 1993-11-17 1997-05-06 Allelix Biopharmaceuticals Inc. Anti-viral guanidino-substituted compounds
US5925552A (en) * 1996-04-25 1999-07-20 Medtronic, Inc. Method for attachment of biomolecules to medical devices surfaces
EP0941122B1 (en) * 1996-08-13 2003-10-29 Chiron Corporation Compositions for polynucleotide delivery
TW499412B (en) * 1996-11-26 2002-08-21 Dimensional Pharm Inc Aminoguanidines and alkoxyguanidines as protease inhibitors
WO1998036743A1 (en) * 1997-02-21 1998-08-27 Cypros Pharmaceutical Corporation Neuroprotective poly-guanidino compounds which block presynaptic n and p/q calcium channels
ES2210761T3 (es) * 1997-05-21 2004-07-01 The Board Of Trustees Of The Leland Stanford Junior University Composicion y procedimiento para mejorar el transporte a traves de las membranas biologicas.
US6072075A (en) * 1997-05-22 2000-06-06 The Regents Of The University Of California Guanidinylation reagents
US6623576B2 (en) * 1998-10-28 2003-09-23 Basf Aktiengesellschaft Continuous manufacture of superabsorbent/ion exchange sheet material
US6222091B1 (en) * 1997-11-19 2001-04-24 Basf Aktiengesellschaft Multicomponent superabsorbent gel particles
US6767904B2 (en) * 1998-03-06 2004-07-27 Bringham Young University Steroid derived antibiotics
US6350738B1 (en) * 1998-03-06 2002-02-26 Brigham Young University Steroid derived antibiotics
US6605115B1 (en) 1999-06-05 2003-08-12 Board Of Trustees Of The Leland Stanford Junior University Method and composition for inhibiting cardiovascular cell proliferation
WO2001013957A2 (en) 1999-08-24 2001-03-01 Cellgate, Inc. Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties

Similar Documents

Publication Publication Date Title
Weissbuch et al. Stochastic “mirror symmetry breaking” via self-assembly, reactivity and amplification of chirality: relevance to abiotic conditions
CA2247889C (en) Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support
JP2005524657A5 (cg-RX-API-DMAC10.html)
JP2011006428A5 (cg-RX-API-DMAC10.html)
JP2010505741A5 (cg-RX-API-DMAC10.html)
ES2721172T3 (es) Una nueva clase de moléculas terapéuticas a base de proteínas
WO2003066069A1 (en) Polymers for delivering peptides and small molecules in vivo
CN102112485B (zh) 乙酸格拉默(glatiramer acetate)的合成
PT95581A (pt) Processo para a preparacao de compostos peptidicos antagonistas do receptor do fibrinogenio
JP2024518476A5 (cg-RX-API-DMAC10.html)
JP2024520234A5 (cg-RX-API-DMAC10.html)
EP1179537B1 (en) Solid phase peptide synthesis method
RU96104348A (ru) Профилактика спида
JP2005519044A5 (cg-RX-API-DMAC10.html)
ES2103252T3 (es) Procedimiento para la preparacion de un dicloruro de acido dicarboxilico.
JP2005502663A5 (cg-RX-API-DMAC10.html)
JP2007536279A5 (cg-RX-API-DMAC10.html)
JP2003522185A5 (cg-RX-API-DMAC10.html)
JP2004537596A (ja) オリゴグアニジン輸送因子の二方向合成
US6194543B1 (en) Dendritic polypeptides
JP2016516079A5 (cg-RX-API-DMAC10.html)
WO2018038166A1 (ja) ポリマー、ポリマーの製造方法、及び薬物複合体
ATE451384T1 (de) Verfahren zur herstellung von peptiden
CA2479625A1 (en) Alkylation of saturated hydrocarbons using interstage distillation
WO1998036743A1 (en) Neuroprotective poly-guanidino compounds which block presynaptic n and p/q calcium channels